BioGrad is undertaking a major expansion with the opening of a new office in Yorkshire, backed by a £3 million investment.
This move is part of BioGrad’s broader national growth strategy, positioning the company at the forefront of scientific and healthcare innovation.
BioGrad, a leading laboratory technology firm, has announced the opening of a new research and teaching office in Yorkshire. This development is driven by a substantial £3 million investment aimed at solidifying BioGrad’s presence in key scientific sectors. The investment will bolster BioGrad’s role in science, healthcare, regenerative medicine, and clinical research in the region.
As a result of its strategic growth, BioGrad now employs approximately 150 individuals. This expansion underlines BioGrad’s commitment to contributing significantly to the scientific landscape.
BioGrad’s CEO, Dr Natalie Kenny, highlighted the importance of this expansion as a pivotal phase for the company. She noted the critical support from regional authorities that facilitated their entry into Yorkshire.
Dr Kenny expressed appreciation for the assistance from key regional figures, acknowledging the strategic advantages Yorkshire offers in terms of its world-class NHS Trust and academic institutions.
The company’s expansion into high-growth sectors aligns with regional economic development goals, fostering innovation and job creation.
He emphasised that the demographic strengths and academic resources in Yorkshire make it an ideal location for such a forward-looking project.
BioGrad Education’s recent achievement as the first North West company to receive backing from the Northern Powerhouse Investment Fund underscores its commitment to growth and development.
BioGrad’s £3 million investment in Yorkshire marks a pivotal step in the company’s national growth, aimed at enhancing its research and educational capabilities.
With strong local support and a clear vision for the future, BioGrad is poised to lead in scientific innovation and healthcare advancement.
